Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria - Scorecard - MDSpire
Advertisement
Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria
Clinical Scorecard: Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
COVID-19 patients in South-Western Nigeria, aged 18 and above
Care Setting
Key Highlights
Lipid profile abnormalities linked to COVID-19 severity, with specific data on cholesterol levels in severe cases.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular assessment of lipid levels and inflammatory markers during and post-recovery, referencing specific guidelines.
Risks
Patient & Prescribing Data
Avoid lipid-lowering drugs or antioxidants prior to biomarker assessment to prevent interference with results.
Clinical Best Practices
Incorporate assessment of oxidative stress and lipid profiles in COVID-19 management, supported by recent studies.
A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.
